These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 8030628)

  • 21. Can estrogen play a significant role in the prevention of Alzheimer's disease?
    Kesslak JP
    J Neural Transm Suppl; 2002; (62):227-39. PubMed ID: 12456066
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Postmenopausal hormone therapy and Alzheimer's disease risk: interaction with age.
    Henderson VW; Benke KS; Green RC; Cupples LA; Farrer LA;
    J Neurol Neurosurg Psychiatry; 2005 Jan; 76(1):103-5. PubMed ID: 15608005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Postmenopausal estrogen replacement therapy and risk of AD: a population-based study.
    Waring SC; Rocca WA; Petersen RC; O'Brien PC; Tangalos EG; Kokmen E
    Neurology; 1999 Mar; 52(5):965-70. PubMed ID: 10102413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estrogen use and early onset Alzheimer's disease: a population-based study.
    Slooter AJ; Bronzova J; Witteman JC; Van Broeckhoven C; Hofman A; van Duijn CM
    J Neurol Neurosurg Psychiatry; 1999 Dec; 67(6):779-81. PubMed ID: 10567497
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A case-control study of endogenous estrogen and risk of Alzheimer's disease].
    Hong X; Zhang X; Li H
    Zhonghua Liu Xing Bing Xue Za Zhi; 2001 Oct; 22(5):379-82. PubMed ID: 11769698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Are sex and educational level independent predictors of dementia and Alzheimer's disease? Incidence data from the PAQUID project.
    Letenneur L; Gilleron V; Commenges D; Helmer C; Orgogozo JM; Dartigues JF
    J Neurol Neurosurg Psychiatry; 1999 Feb; 66(2):177-83. PubMed ID: 10071096
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intermittent fasting protects against the deterioration of cognitive function, energy metabolism and dyslipidemia in Alzheimer's disease-induced estrogen deficient rats.
    Shin BK; Kang S; Kim DS; Park S
    Exp Biol Med (Maywood); 2018 Feb; 243(4):334-343. PubMed ID: 29307281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors for parkinson's disease: the leisure world cohort study.
    Paganini-Hill A
    Neuroepidemiology; 2001 May; 20(2):118-24. PubMed ID: 11359079
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association Between Lithium Use and Risk of Alzheimer's Disease.
    Cheng C; Zandi P; Stuart E; Lin CH; Su PY; Alexander GC; Lan TH
    J Clin Psychiatry; 2017 Feb; 78(2):e139-e145. PubMed ID: 28002662
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Head trauma and the risk of Alzheimer's disease.
    van Duijn CM; Tanja TA; Haaxma R; Schulte W; Saan RJ; Lameris AJ; Antonides-Hendriks G; Hofman A
    Am J Epidemiol; 1992 Apr; 135(7):775-82. PubMed ID: 1595677
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Frailty in Relation to the Risk of Alzheimer's Disease, Dementia, and Death in Older Chinese Adults: A Seven-Year Prospective Study.
    Wang C; Ji X; Wu X; Tang Z; Zhang X; Guan S; Liu H; Fang X
    J Nutr Health Aging; 2017; 21(6):648-654. PubMed ID: 28537328
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Estrogens and Alzheimer disease].
    Stähelin HB
    Schweiz Med Wochenschr; 1999 Dec; 129(49):1920-5. PubMed ID: 10635084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk of head and traumatic brain injuries associated with antidepressant use among community-dwelling persons with Alzheimer's disease: a nationwide matched cohort study.
    Taipale H; Koponen M; Tanskanen A; Lavikainen P; Sund R; Tiihonen J; Hartikainen S; Tolppanen AM
    Alzheimers Res Ther; 2017 Aug; 9(1):59. PubMed ID: 28764750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estrogen, cognition, and a woman's risk of Alzheimer's disease.
    Henderson VW
    Am J Med; 1997 Sep; 103(3A):11S-18S. PubMed ID: 9344402
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hormone replacement therapy and Alzheimer's disease.
    van Duijn CM
    Maturitas; 1999 Mar; 31(3):201-5. PubMed ID: 10340279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased longevity in older users of postmenopausal estrogen therapy: the Leisure World Cohort Study.
    Paganini-Hill A; Corrada MM; Kawas CH
    Menopause; 2018 Nov; 25(11):1256-1261. PubMed ID: 30358721
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of Alzheimer's disease, cerebrovascular disease and dementia in women: the case for menopause hormone therapy.
    Davey DA
    Neurodegener Dis Manag; 2017 Feb; 7(1):85-94. PubMed ID: 28074678
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postmenopausal hormone therapy and Alzheimer's disease, dementia, and Parkinson's disease: A systematic review and time-response meta-analysis.
    Wu M; Li M; Yuan J; Liang S; Chen Z; Ye M; Ryan PM; Clark C; Tan SC; Rahmani J; Varkaneh HK; Bhagavathula AS
    Pharmacol Res; 2020 May; 155():104693. PubMed ID: 32057896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of estrogen therapy on Alzheimer's disease: a fork in the road?
    Brinton RD
    CNS Drugs; 2004; 18(7):405-22. PubMed ID: 15139797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Familial aggregation of Alzheimer's disease and related disorders: a collaborative re-analysis of case-control studies.
    van Duijn CM; Clayton D; Chandra V; Fratiglioni L; Graves AB; Heyman A; Jorm AF; Kokmen E; Kondo K; Mortimer JA; Rocca WA; Shalat SL; Soininen H; Hofman A;
    Int J Epidemiol; 1991; 20 Suppl 2():S13-20. PubMed ID: 1833349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.